Acquisition - HealthQuill

AbbVie Inc., operating in therapeutic areas such as immunology, oncology, neuroscience, and eye care, announced a pact to acquire ImmunoGen, Inc., for $10.1 billion. Image Credit: AbbVie

AbbVie to buy Immunogen for $10.1b to expand solid tumour market

HQ Team November 30, 2023: AbbVie Inc., operating in therapeutic areas such as immunology, oncology, neuroscience, and eye care, announced a pact to.

by HealthQuill
November 30, 2023
0 Comments

Shareholders of Abcam Plc., a UK-based manufacturer and supplier of antibodies and reagents used for medical research, have approved a plan from US’s Danaher Corp to acquire the company for $5.7 billion.

Drugs Health Pharma

Abcam shareholders approve Danaher Corp acquisition for $5.7 billion

HQ Team November 7, 2023: Shareholders of Abcam Plc., a UK-based manufacturer and supplier of antibodies and reagents used for medical research, have.

by HealthQuill
November 7, 2023
0 Comments

Bristol Myers Squibb, one of the world’s largest pharmaceutical companies, will acquire Mirati Therapeutics for $5.8 billion through a combination of cash and debt to broaden its cancer portfolio.

Drugs Health Pharma

Bristol Myers acquires Mirati Therapeutics for $5.8 billion

HQ Team October 9, 2023: Bristol Myers Squibb, one of the world’s largest pharmaceutical companies, will acquire Mirati Therapeutics for $5.8 billion through.

by HealthQuill
October 9, 2023
0 Comments

Amgen Inc., a US biotechnology company, completed the acquisition of Horizon Therapeutics Plc for $27.8 billion, gaining access to the Dublin-based firm’s two drugs that treat rare inflammatory diseases.

Drugs Health Pharma

Amgen completes $27.8b acquisition of Horizon Therapeutics

Amgen Inc., a US biotechnology company, completed the acquisition of Horizon Therapeutics Plc for $27.8 billion, gaining access to the Dublin-based firm’s two.

by HealthQuill
October 7, 2023
0 Comments

Cordis, a US-based medical device maker, has acquired Switzerland’s MedAlliance for up to $1.1 billion to expand its product portfolio.

Health Medical Pharma

Cordis acquires medical device maker MedAlliance for $1.1 billion

HQ Team October 2, 2023: Cordis, a US-based medical device maker, has acquired Switzerland’s MedAlliance for up to $1.1 billion to expand its.

by HealthQuill
October 2, 2023
0 Comments

Biocon Ltd., an Indian biopharmaceutical company, has acquired Eywa Pharma Inc., an oral solid dosage manufacturing facility in the US for $7.7 million.

Drugs Health Pharma

Biocon buys Eywa Pharma’s US facility for $7.7 million

HQ Team September 6, 2023: Biocon Ltd., an Indian biopharmaceutical company, has acquired Eywa Pharma Inc., an oral solid dosage manufacturing facility in.

by HealthQuill
September 6, 2023
0 Comments

Eli Lily sold its sugar-controlling drug to Amphastar Pharmaceuticals for $1.07 billion.

Drugs Health Pharma

Eli Lilly to sell diabetic nasal drug to Amphastar for $1.07 billion

Eli Lily sold its sugar-controlling drug to Amphastar Pharmaceuticals for $1.07 billion.

by HealthQuill
April 25, 2023
0 Comments

US-based Merck will buy Prometheus Biosciences for about 10.8 billion to shore up its immunology portfolio to shield itself from eventual revenue loss as patents on its cancer immunotherapy Keytruda expires by the end of the decade.

Drugs Pharma

Merck to acquire Prometheus for $10.8 billion to step up immunology presence

HQ Team April 17, 2023: US-based Merck will buy Prometheus Biosciences for about 10.8 billion to shore up its immunology portfolio to shield itself from.

by HealthQuill
April 17, 2023
0 Comments

Dr. Reddy’s Laboratories, an Indian maker of generics and active pharmaceutical ingredients, has completed the acquisition of Mayne Pharma’s U.S. generic prescription portfolio.

Drugs Health Medical Pharma

Dr. Reddy’s completes Mayne Pharma’s U.S. portfolio buyout

H.Q. Team April 7, 2023: Dr. Reddy’s Laboratories, an Indian maker of generics and active pharmaceutical ingredients, has completed the acquisition of Mayne.